The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Aspirin Foundation; Bayer
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Clovis Oncology (Inst); Genzyme (Inst); Janssen (Inst); Novartis (Inst); Sanofi (Inst)
DNA methylation signature predictive of benefit from neoadjuvant chemotherapy in esophageal adenocarcinoma: Results from the MRC OEO2 phase III trial.
 
Raghav Sundar
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Roche; Taiho Pharmaceutical
 
Alvin Ng
No Relationships to Disclose
 
Hermioni Zouridis
No Relationships to Disclose
 
Taotao Sheng
No Relationships to Disclose
 
Shenli Zhang
No Relationships to Disclose
 
Ming Hui Lee
No Relationships to Disclose
 
Nisha Padmanabhan
No Relationships to Disclose
 
Wen Fong Ooi
Patents, Royalties, Other Intellectual Property - A-STAR
 
Aditi Qamra
No Relationships to Disclose
 
Matthew Guy Nankivell
No Relationships to Disclose
 
Ruth E. Langley
No Relationships to Disclose
 
William H. Allum
Honoraria - Lilly; Nestle Health Science
 
David Cunningham
Research Funding - 4SC (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Merrimack (Inst); Sanofi (Inst)
 
Heike I Grabsch
No Relationships to Disclose
 
Patrick Tan
Stock and Other Ownership Interests - HealthSeq
Research Funding - Kyowa Hakko Kirin; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Agency for Science Technology and Research